Therapeutic Solutions International Inc
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulfora… Read more
Therapeutic Solutions International Inc (TSOI) - Total Liabilities
Latest total liabilities as of September 2024: $1.92 Million USD
Based on the latest financial reports, Therapeutic Solutions International Inc (TSOI) has total liabilities worth $1.92 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Therapeutic Solutions International Inc - Total Liabilities Trend (2007–2023)
This chart illustrates how Therapeutic Solutions International Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Therapeutic Solutions International Inc Competitors by Total Liabilities
The table below lists competitors of Therapeutic Solutions International Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INTERTEK GROUP
BE:IT1
|
Germany | €2.28 Billion |
|
Lancaster Resources Inc.
PINK:LANRF
|
USA | $1.95 Million |
|
Diagonal Bio AB
ST:DIABIO
|
Sweden | Skr2.13 Million |
|
YANGAROO Inc
PINK:YOOIF
|
USA | $3.79 Million |
|
Pasinex Resources Limited
PINK:PSXRF
|
USA | $3.90 Million |
|
Brand Group (M.G) Ltd
TA:BRND
|
Israel | ILA615.29 Million |
Liability Composition Analysis (2007–2023)
This chart breaks down Therapeutic Solutions International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Therapeutic Solutions International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Therapeutic Solutions International Inc (2007–2023)
The table below shows the annual total liabilities of Therapeutic Solutions International Inc from 2007 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $2.01 Million | -9.48% |
| 2022-12-31 | $2.22 Million | -11.90% |
| 2021-12-31 | $2.52 Million | +5.84% |
| 2020-12-31 | $2.38 Million | +1.51% |
| 2019-12-31 | $2.35 Million | +16.29% |
| 2018-12-31 | $2.02 Million | +50.45% |
| 2017-12-31 | $1.34 Million | +76.50% |
| 2016-12-31 | $759.71K | +128.48% |
| 2015-12-31 | $332.50K | 0.00% |
| 2014-12-31 | $332.50K | -57.71% |
| 2013-12-31 | $786.20K | +99.31% |
| 2012-12-31 | $394.45K | -87.50% |
| 2011-12-31 | $3.16 Million | +11185.56% |
| 2010-12-31 | $27.97K | +116.85% |
| 2009-12-31 | $12.90K | +77.89% |
| 2008-12-31 | $7.25K | +36.53% |
| 2007-12-31 | $5.31K | -- |